Runbo Zhong

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Topics

Polycyclic Aromatic Hydrocarbons

Brain Metastases

Top Venues

International journal of nanomedicine

Respiratory research

Cancer biology & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yingqi Xu, Hao Ji, Yidan Zhang, Liwen Xiong, Baohui Han, Hua Zhong, Jianlin Xu, Runbo Zhong
Combination of EGFR-TKI and Chemotherapy Versus EGFR-TKI Monotherapy as Neoadjuvant Treatment of Stage III-N2 EGFR-Mutant Non-Small Cell Lung Cancer. The oncologist 29 (7) (2024)
Liang Zheng, Fang Hu, Wei Nie, Jun Lu, Bo Zhang, Jianlin Xu, Shuyuan Wang, Ying Li, Xiaoxuan Zheng, Wei Zhang, Yinchen Shen, Runbo Zhong, Tianqing Chu, Bao-Hui Han, Hua Zhong, Xueyan Zhang
The prognosis and metabolite changes of NSCLC patients receiving first-line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classification. Cancer medicine 13 (17) (2024)
Yingqi Xu, Hao Ji, Yidan Zhang, Liwen Xiong, Baohui Han, Hua Zhong, Jianlin Xu, Runbo Zhong
Combination of EGFR-TKI and Chemotherapy Versus EGFR-TKI Monotherapy as Neoadjuvant Treatment of Stage III-N2 EGFR-Mutant Non-Small Cell Lung Cancer. The oncologist 29 (7) (2024)
Yingqi Xu, Hao Ji, Yidan Zhang, Liwen Xiong, Baohui Han, Hua Zhong, Jianlin Xu, Runbo Zhong
Combination of EGFR-TKI and Chemotherapy Versus EGFR-TKI Monotherapy as Neoadjuvant Treatment of Stage III-N2 EGFR-Mutant Non-Small Cell Lung Cancer. The oncologist 29 (7) (2024)
Yaohua Hu, Yidan Zhang, You Lu, Yingqi Xu, Jianlin Xu, Hua Zhong, Lei Cheng, Runbo Zhong
Heterogeneity in PD-L1 expression between primary and metastatic lymph nodes: a predictor of EGFR-TKI therapy response in non-small cell lung cancer. Respiratory research 25 (1) (2024)
Dongfang Chen, Jianlin Xu, Yizhuo Zhao, Baohui Han, Runbo Zhong
Prognostic value of pretreatment procalcitonin and neutrophil-lymphocyte ratio in extensive-stage small-cell lung cancer. Cancer biology & therapy 25 (1) (2024)
Dongfang Chen, Jianlin Xu, Yizhuo Zhao, Baohui Han, Runbo Zhong
Prognostic value of pretreatment procalcitonin and neutrophil-lymphocyte ratio in extensive-stage small-cell lung cancer. Cancer biology & therapy 25 (1) (2024)
Yingqi Xu, Hao Ji, Yidan Zhang, Liwen Xiong, Baohui Han, Hua Zhong, Jianlin Xu, Runbo Zhong
Combination of EGFR-TKI and Chemotherapy Versus EGFR-TKI Monotherapy as Neoadjuvant Treatment of Stage III-N2 EGFR-Mutant Non-Small Cell Lung Cancer. The oncologist (2024)
Yaohua Hu, Yidan Zhang, You Lu, Yingqi Xu, Jianlin Xu, Hua Zhong, Lei Cheng, Runbo Zhong
Heterogeneity in PD-L1 expression between primary and metastatic lymph nodes: a predictor of EGFR-TKI therapy response in non-small cell lung cancer. Respiratory research 25 (1) (2024)
Yingqi Xu, Hao Ji, Yidan Zhang, Liwen Xiong, Baohui Han, Hua Zhong, Jianlin Xu, Runbo Zhong
Combination of EGFR-TKI and Chemotherapy Versus EGFR-TKI Monotherapy as Neoadjuvant Treatment of Stage III-N2 EGFR-Mutant Non-Small Cell Lung Cancer. The oncologist 29 (7) (2024)
Yaohua Hu, Yidan Zhang, You Lu, Yingqi Xu, Jianlin Xu, Hua Zhong, Lei Cheng, Runbo Zhong
Heterogeneity in PD-L1 expression between primary and metastatic lymph nodes: a predictor of EGFR-TKI therapy response in non-small cell lung cancer. Respiratory research 25 (1) (2024)
Dongfang Chen, Jianlin Xu, Yizhuo Zhao, Baohui Han, Runbo Zhong
Prognostic value of pretreatment procalcitonin and neutrophil-lymphocyte ratio in extensive-stage small-cell lung cancer. Cancer biology & therapy 25 (1) (2024)
Lian Yu, Yaohua Hu, Jianlin Xu, Rong Qiao, Hua Zhong, Bao-Hui Han, Jinjing Xia, Runbo Zhong
Multi-target angiogenesis inhibitor combined with PD-1 inhibitors may benefit advanced non-small cell lung cancer patients in late line after failure of EGFR-TKI therapy. International journal of cancer (2023)
Bo Zhang, Hua Zhong, Chunlei Shi, Zhiqiang Gao, Runbo Zhong, Aiqin Gu, Weimin Wang, Tianqing Chu, Liwen Xiong, Wei Zhang, Huimin Wang, Xueyan Zhang, Bao-Hui Han
Rationale and design of a multicenter, randomized phase II trial of durvalumab with or without multitarget tyrosine kinase inhibitor as maintenance treatment in extensive-stage small-cell lung cancer patients (DURABLE study). The clinical respiratory journal (2023)
Jun Lu, Yuqing Lou, Yanwei Zhang, Runbo Zhong, Wei Zhang, Xueyan Zhang, Huimin Wang, Tianqing Chu, Baohui Han, Hua Zhong
Paclitaxel Has a Reduced Toxicity Profile in Healthy Rats After Polymeric Micellar Nanoparticle Delivery. International journal of nanomedicine 18 (2023)
Jun Lu, Yuqing Lou, Yanwei Zhang, Runbo Zhong, Wei Zhang, Xueyan Zhang, Huimin Wang, Tianqing Chu, Baohui Han, Hua Zhong
Paclitaxel Has a Reduced Toxicity Profile in Healthy Rats After Polymeric Micellar Nanoparticle Delivery. International journal of nanomedicine 18 (2023)
Jun Lu, Yuqing Lou, Yanwei Zhang, Runbo Zhong, Wei Zhang, Xueyan Zhang, Huimin Wang, Tianqing Chu, Baohui Han, Hua Zhong
Paclitaxel Has a Reduced Toxicity Profile in Healthy Rats After Polymeric Micellar Nanoparticle Delivery. International journal of nanomedicine 18 (2023)
Lian Yu, Jianlin Xu, Rong Qiao, Bao-Hui Han, Hua Zhong, Runbo Zhong
Efficacy and safety of anlotinib combined with PD-1/PD-L1 inhibitors as second-line and subsequent therapy in advanced small-cell lung cancer. Cancer medicine (2022)
Rong Qiao, Mengxia Li, Runbo Zhong, Yujie Wei, Jun Wang, Zheng Zhang, Ling Wang, Tian Xu, Yue Wang, Liping Dai, Wanjian Gu, Baohui Han, Rongxi Yang
The Association Between PNPLA2 Methylation in Peripheral Blood and Early-Stage Lung Cancer in a Case-Control Study. Cancer management and research 13 (2021)
Dongfang Chen, Jianlin Xu, Rong Qiao, Yizhuo Zhao, Tianqing Chu, Bao-Hui Han, Runbo Zhong
Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of oncology 2020 (2020)
Yuqing Lou, Runbo Zhong, Jianlin Xu, Rong Qiao, Jiajun Teng, Yanwei Zhang, Xueyan Zhang, Tianqing Chu, Hua Zhong, Bao-Hui Han
Does surgically resected small-cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation? Thoracic cancer 11 (5) (2020)
Dongfang Chen, Jianlin Xu, Yizhuo Zhao, Tianqing Chu, Hua Zhong, Baohui Han, Runbo Zhong
Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib. Journal of cancer research and clinical oncology 146 (2) (2019)